Many stocks are on the move this morning, and not all from earnings. The top day trader and active trader alerts are in American Capital, Ltd. (NASDAQ: ACAS), Beazer Homes USA Inc. (NYSE: BZH), BP plc (NYSE: BP), Garmin Ltd. (NASDAQ: GRMN), InterMune Inc. (NASDAQ: ITMN), Melco Crown Entertainment Limited (NASDAQ: MPEL), Myriad Genetics Inc. (NASDAQ: MYGN), Osiris Therapeutics, Inc. (NASDAQ: OSIR), and Ryanair Holdings plc (NASDAQ: RYAAY) are all on the move this morning. We have details and color on each where applicable.
American Capital, Ltd. (NASDAQ: ACAS) is up after earnings: Q1 EPS was $0.17 versus $0.09 expected from Thomson Reuters; net asset value was listed as $8.98 vs. $8.29 a year ago and versus the $6.09 close yesterday. Shares are up over 4% at $6.32 on about 80,000 shares.
Beazer Homes USA Inc. (NYSE: BZH) is up this morning after pricing its 12.5 million shares secondary offering at $5.81 after a close of $5.81 and a close of $6.88 on Monday. Shares are up over 2% at $5.92 on active volume.
BP plc (NYSE: BP) is trading up over 2% at $51.51 on over 1 million shares as the damages it owes may be severely capped by disaster laws and as traders try to look for a bottom.
Garmin Ltd. (NASDAQ: GRMN) is trading lower after $0.38 EPS and a 1% revenue drop to $431 million versus Thomson Reuters estimates of $0.42 EPS and $484.5 million. Shares are trading down 11.7% at $33.10 versus a 52-week range of $19.40 to $40.47.
InterMune Inc. (NASDAQ: ITMN) is the worst stock on NASDAQ with shares down almost 80%. Full news at BioHealthInvestor.com on the FDA major delay in complete response letter. Shares are down 77% at $10.13 on 4 million shares. The prior 52-week range was $10.48 to $49.46 and this was a $9.00 stock last night at the re-open from the Halt.
Melco Crown Entertainment Limited (NASDAQ: MPEL) is trading down after a Goldman Sachs SELL rating this morning. Shares closed at $4.60, but shares are down almost 5% at $4.38 on over 85,000 shares.
Myriad Genetics Inc. (NASDAQ: MYGN) is the second worse performer on disappointing earnings and guidance.
Osiris Therapeutics, Inc. (NASDAQ: OSIR) is up 12% at $8.50, but on very thin volume. The company receives from the FDA an Orphan Drug Designation for its stem cell treatment for Type-1 diabetes.
Ryanair Holdings plc (NASDAQ: RYAAY) is down after another cut to the PIIGS in Portugal and on continued worry over business from teh Iceland volcano. Shares closed at $27.14 and ADR shares are down 3.1% at $26.30 on about 15,000 shares.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG